DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.
Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.
Top 10 Integrated Utility Stocks To Buy Right Now: Lpath Inc (LPTN)
Lpath, Inc. (Lpath), incorporated on September 18, 2002, is a biotechnology company focused on the discovery and development of bio-active lipid-targeted monoclonal antibody (mAb) therapeutics. The Company has three product candidates, iSONEP, ASONEP and Lpathomab. The Company's program, iSONEP, is a mAb against Sphingosine-1-Phosphate (S1P). As of December 31, 2012, it was in phase-II clinical trials for wet Age-Related Macular Degeneration. The Company is also advancing ASONEP, the systemic formulation of the mAb to S1P. ASONEP has completed a phase-I clinical trial and is entering phase-II clinical trials in Renal Cell Carcinoma.
Lpath's third product candidate, Lpathomab, is a mAb to the bioactive lipid, Lysophosphatidic Acid (LPA). The Company also applies its technology platform, ImmuneY2, to discovering mAbs to new bioactive lipid targets.
Advisors' Opinion:- [By Lauren Pollock]
Biotechnology company Lpath Inc.(LPTN) warned Pfizer Inc.(PFE) may divest itself of its exclusive option to co-develop the smaller firm’s leading product candidate. Lpath’s stock fell.
- [By Lauren Pollock]
Lpath Inc.(LPTN) said it is no longer actively seeking to reacquire exclusive rights to its leading product candidate from Pfizer Inc.(PFE), saying the pharmaceutical giant informed the company that its offers weren’t competitive. The biotechnology company in October had warned that Pfizer might may divest itself of its exclusive option to co-develop the smaller firm’s leading product candidate–known as iSONEP.
Top 10 Tech Stocks To Own For 2014: Intevac Inc.(IVAC)
Intevac, Inc. provides process manufacturing equipment solutions to the hard disk drive industry, and process manufacturing equipment and inspection solutions to the photovoltaic industry. The company operates in two segments, Equipment and Intevac Photonics. The Equipment segment designs, develops, and markets magnetic disks; hard disk drive equipment products, including disk sputtering and disk lubrication systems; technology upgrades; and spare parts and consumables, as well as installation, maintenance, and repair services. This segment also offers capital equipment for the photovoltaic solar manufacturing industry. The Intevac Photonics segment develops, manufactures, and sells digital-optical products for the capture and display of low-light images and materials identification used in military aircraft, ground vehicles, ground soldier head-mounted, and weapon-mounted applications. This segment also provides sensors, cameras, and systems for military applications; Ram an spectrometer table-top and handheld systems for use in forensics, homeland security, geology, gemology, medical, pharmaceutical, and industrial quality assurance applications; and low-light cameras for industrial inspection, bio-medical, and scientific applications. The company sells its products through direct sales force, system integrators, distributors, and value added resellers in the United States, Asia, Europe, and rest of world. Intevac, Inc. was founded in 1990 and is headquartered in Santa Clara, California.
Advisors' Opinion:- [By Roberto Pedone]
Intevac (IVAC) provides process manufacturing equipment solutions to the hard disk drive industry and high-productivity process manufacturing equipment and inspection solutions to the photovoltaic industry. This stock closed up 8.5% to $6.74 in Tuesday's trading session.
Tuesday's Range: $6.23-$6.75
52-Week Range: $4.06-$6.80
Tuesday's Volume: 263,000
Three-Month Average Volume: 140,032From a technical perspective, IVAC soared higher here right off some near-term support at $6.25 with above-average volume. This stock has been uptrending strong for the last three months, with shares moving higher from its low of $4.31 to its recent high of $6.80. During that move, shares of IVAC have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of IVAC within range of triggering a major breakout trade. That trade will hit if IVAC manages to take out its 52-week high at $6.80 with high volume.
Traders should now look for long-biased trades in IVAC as long as it's trending above some near-term support levels at $6.25 or at $5.92 and then once it sustains a move or close above its 52-week high at $6.80 with volume that hits near or above 140,032 shares. If that breakout hits soon, then IVAC will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at $8 to $8.37. Any high-volume move above those levels will then put $9 to $9.36 within range for shares of IVAC.
Top 10 Tech Stocks To Own For 2014: AutoNavi Holdings Limited(AMAP)
AutoNavi Holdings Limited provides digital map content, and navigation and location-based solutions in the People?s Republic of China (PRC). The company offers digital map data to various automobile manufacturers for in-dash navigation systems; and navigation solutions for use in in-dash navigation system to portable navigation device manufacturers based on their specific needs, which range from digital map data only to a digital map data, a navigation engine, and an user interface. It provides mobile/Internet location-based solutions to a mobile operator; mobile and Internet-based map application solutions that allow Web sites to embed location-based services capabilities into their Internet and enterprise applications; and MiniMap, an user-end map application software. The company also offers aerial digital maps and 3-D modeling applications to certain PRC government agencies and enterprises to meet their land usage survey, specific needs for 3-D geographic information, and other needs pursuant to a service contract arrangement. In addition, it has collaboration with certain mobile phone and tablet computer manufacturers and mobile operators to pre-install its navigation solutions. The company is headquartered in Beijing, China.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
AutoNavi Holdings (NASDAQ: AMAP) shot up 24.18 percent to $20.54 on Alibaba $21.00 per ADS offer.Shares of MannKind (NASDAQ: MNKD) were up as well, gaining 5.75 percent to $5.70 despite little news on the name during Monday's session.
Top 10 Tech Stocks To Own For 2014: CDW Corp (CDW)
CDW Corporation (CDW), incorporated on May 25, 2007, is a provider of integrated information technology (IT) solutions in the United States and Canada. Its range of offerings range from discrete hardware and software products to integrated IT solutions, such as mobility, security, data center optimization, cloud computing, virtualization and collaboration. The Company has two segments: Corporate and Public. Corporate segment consists of primarily of private sector business customers. Public segment consists of government agencies and education and healthcare institutions. CDW also has two other operating segments, CDW Advanced Services and Canada (combined together as Other). The Company is a sales channel partner for many original equipment manufacturers (OEMs) and software publishers (collectively, its vendor partners), whose products it sells or include in the solutions CDW offers. The Company helps its customer base of more than 250,000 small, medium and large business, government, education and healthcare customers by delivering solutions to their IT needs.
The Company�� Corporate segment is divided into a medium-large business customer channel, primarily serving customers with more than 100 employees, and a small business customer channel, primarily serving customers with up to 100 employees. The CDW Advanced Services business consists primarily of customized engineering services delivered by technology specialists and engineers and managed services that include infrastructure as a service (IaaS) offerings. The Company�� product portfolio includes more than 100,000 products from more than 1,000 brands. Revenues from the sale of hardware, software, custom configuration and third-party provided services are recorded within its Corporate and Public segments.
The Company�� revenue from professional services is either recognized as incurred for services billed at an hourly rate or recognized using a proportional performance model for services provided at a fixed fee.! Revenue from software as a service (SaaS) arrangements, IaaS arrangements, and data center services, including Internet connectivity, Web hosting, server co-location and managed services, is recognized over the period service is provided. The Company also sells certain products for which it acts as an agent. Products in this category include the sale of third-party services, warranties or software assurance (SA) or third-party-hosted SaaS and IaaS arrangements. The Company offer over 1,000 brands, from companies, such as APC, Apple, Cisco, EMC, Hewlett-Packard, IBM, Lenovo, Microsoft, NetApp, Symantec and VMware, to vendor partners, such as Drobo, Fusion-io, Meraki, Nimble Storage, Salesforce.com, Sophos and Splunk.
The Company competes with Dimension Data, ePlus, Insight Enterprises, PC Connection, PCM, Presidio, Softchoice, World Wide Technology, Dell, Hewlett-Packard, Apple, Amazon, Newegg, TigerDirect.com, Buy.com, IBM, Accenture, Staples, Office Depot and Office Max.
Advisors' Opinion:- [By Rich Smith]
Just over six years after leaving the public stock markets in a $7.3 billion leveraged buyout, IT equipment supplier CDW (NASDAQ: CDW ) is back on the Nasdaq again!
- [By Jon C. Ogg]
Before you consider this just to be a bit of IPO pondering, take a step back and understand that some of this list membership already has�filed to come public or actually has�made it public recently. Boise Cascade Co. (NYSE: BCC), CDW Corp. (NASDAQ: CDW), Coty Inc. (NYSE: COTY), Global Brass and Copper Holdings Inc. (NYSE: BRSS), Noodles & Company (NASDAQ: NDLS), Restoration Hardware Holdings Inc. (NYSE: RH), Sprouts Farmers Market Inc. (NASDAQ: SFM) and many others are on the list and have made it to the post-IPO stage in the stock market.
Top 10 Tech Stocks To Own For 2014: Medical Cannabis Payment Solutions (REFG)
Medical Cannabis Payment Solutions, incorporated on December 1, 2005, is a provider of integrated supply and distribution technology. The Company�� Seed-to-Sale (S2S) integrated solution is a management and compliance technology for growers, caregivers and dispensaries in the market. The Company also works with public officials and government agencies to expand the acceptance of medicinal cannabis, and the adoption of a legal framework where maximum market expansion is possible. The Company solves the fragmentation problem by identifying tools that are important to dispensaries, and customizing those tools specifically catered to the industry. The Company's solutions include Spark, Ghost and S2S.
Spark
The Company�� SPARK Hosted Voice over Internet Protocol (VoIP) provides customers with enterprise-class hosted phone systems customized to fit customers��needs. SPARK's service is a fully-managed, cloud-based system. The Company offers the convenience of an online Internet Protocol (IP)-based telecommunications system while still delivering substantial savings to customers bottom line.
Ghost
By offering customers a customized, tailored mobile solution, the Company's Ghost Mobile Apps give a marketing tool with a texting and e-mail solution, keeping customers in constant contact with patients and clients. The Company creates an optimized experience in context to each device or screen size.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Fresh Start Private Management Inc (OTCMKTS: CEYY), 7 Star Entertainment Inc (OTCMKTS: SAEE) and Refill Energy, Inc (OTCMKTS: REFG) have been getting some attention lately in various investment newsletters thanks to paid promotions. Of course, there is nothing wrong with a properly disclosed promotional or investor relations campaign, but unwary investors or traders could find themselves in trouble if they are not careful. So do these three small caps have what it takes to remain hot? Here is a quick reality check before you invest or trade:
- [By Peter Graham]
What�� the Catch With Alternative Energy Partners Inc? According to various disclosures, no transactions have occurred to mention Alternative Energy Partners in various investment newsletters and there is no recent news from the company. In fact, the most recent press release from Alternative Energy Partners dates from September to announce the launch of the beta version of http://www.pharmajanes.com ��its website for delivery of medical marijuana products. As of September, the PharmaJanes beta platform was only available online with the mobile application set to follow after the official launch of the online platform. Otherwise and according to the latest Form 10-Q filed on December 23rd, the company agreed to acquire the PharmaJanesTM marketing operation from iEquity Corp. back in May 2013 and will be changing its business model to focus purely in the medical marijuana marketing space. In addition, AEGY will be changing its name to PharmaJanes, Inc. Otherwise, someone by the name of Mario Barrera currently serves as Chairman, President and CEO and sole officer and the company has no paid employees ��relying instead on paid consultants to provide necessary services. A look at Alternative Energy Partners��financials reveals revenues of zero (most recent reported quarter), ��3k, $1k and $1k for the past four quarters along not income of $230k (most recent reported quarter) and net losses of $2,954k, $51k and $452k. At the end of October, Alternative Energy Partners had $2,031k in current liabilities and $237k in long term debt. So while investors or traders got a high on Monday (and last Friday as well), it does not look like a sustainable high.
Medical Cannabis Payment Solutions (OTCMKTS: REFG) Wants to Provide Bank and Payment Accessibility to Marijuana DispensariesSmall cap Medical Cannabis Payment Solutions��mission is to provide end-to-end management, across multiple management systems, for medicinal marijuan
Top 10 Tech Stocks To Own For 2014: Regeneron Pharmaceuticals Inc.(REGN)
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. The company?s commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. Its products under Phase III clinical development stage consist of VEGF Trap-Eye, an aflibercept ophthalmic solution developed using intraocular delivery for the treatment of serious eye diseases; ARCALYST for the prevention of gout flares in patients initiating uric acid-lowering treatment; and Aflibercept (VEGF Trap), which is developed in oncology. The company?s earlier stage clinical programs include various human antibodies, such as REGN727 for low-density lipoprotein cholesterol reduction, REGN88 for rheumatoid arthritis and ankylosing spondylitis; REGN668 for atopic dermatitis and asthma; REGN421 and REGN910 for oncology; REGN475 for the treatment of pain; and REGN728 and REGN846. It also conducts preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. The company distributes its products through third party service providers. It has strategic collaboration with sanofi-aventis Group to discover, develop, and commercialize human monoclonal antibodies; and Bayer HealthCare LLC to develop and commercialize VEGF Trap. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is based in Tarrytown, New York.
Advisors' Opinion:- [By Mani]
The safety and tolerability profile for Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) anti-PCSK9 antibody Alirocumab is in good stead against Amgen's AMG145, and supports upside potential of the Regeneron antibody in the multi-billion dollar market for cholesterol lowering drugs.
- [By Dan Carroll]
Fellow major biotech stock Regeneron (NASDAQ: REGN ) lost 5% during the week, part of a sustained 15% slump over the past month. Like Biogen, however, Regeneron's a company with a drug preparing for a strong future. The company's asthma therapy dupilumab, made jointly with Big Pharma's Sanofi, absolutely crushed a mid-stage clinical trial by paring asthmatic episodes back 87%. While the drug will need to proceed through later-stage trials before reaching the approval stage, things are looking up for this potentially high-flying asthma therapy in a highly lucrative market.
- [By Grace L. Williams]
You�� hardly know biotech Regeneron Pharmaceuticals (REGN) reported a mixed first quarter this morning. Although the stock is down now, shares popped earlier, trading up as much as 1.8% around 10:30 a.m. before simmering down.
For the period ended March 31, Regeneron reported earnings of $2.26 a share or $263 million, up from $1.78 or $201 million year-over-year. Revenue rose to $626 million compared to $440 million. Analysts polled by Thomson Reuters most recently forecast earnings of $2.20 a share, on sales of $610 million. The big downer: Disappointing sales of Regeneron’s eye treatment, Eylea.
Citigroup analyst Yaron Werber, however, calls the weak sales a temporary setback and considers weakness in Regeneron a buying opportunity. He explains why:
Eylea sales were a miss at $356 million versus our $409 million and Consensus $404 million, impacted by a decrease in distributor inventory and typically weak first quarter. Unit demand for Eylea grew by 25% year-over-year excluding inventory. The guidance was re-affirmed and we expect sales to bounce back in the second quarter and benefit from DME approval in the third quarter of 2014…This quarter was anticipated to be weak and any weakness in the stock provides an entry point ahead of a robust year of data for Alirocumab and dupilumab, ongoing strong ex-US launch of Eylea and expected approval in DME in the US by August 18th.
Shares of Regeneron have dropped 1.7% to $281.81 at 3:116 p.m. The iShares Nasdaq Biotechnology ETF (IBB) has fallen 2% to $222.94, while the SPDR S&P Biotech ETF (XBI) has slid 3.8% to $120.
Top 10 Tech Stocks To Own For 2014: Texas Instruments Incorporated(TXN)
Texas Instruments Incorporated engages in the design and sale of semiconductors to electronics designers and manufacturers worldwide. The company?s Analog segment offers high-performance analog products comprising standard analog semiconductors, such as amplifiers, data converters, and interface semiconductors; high-volume analog and logic products; and power management semiconductors and line-powered systems. Its Embedded Processing segment includes DSPs that perform mathematical computations to process and enhance digital data; and microcontrollers, which are designed to control a set of specific tasks for electronic equipment. The company?s Wireless segment designs, manufactures, and sells application processors and connectivity products. Its Other segment offers smaller semiconductor products, which include DLP products that are primarily used in projectors to create high-definition images; and application-specific integrated circuits. This segment also provides handhe ld graphing and scientific calculators, as well as licenses technologies to other electronic companies. The company serves the communications, computing, industrial, consumer electronics, automotive, and education sectors. Texas Instruments Incorporated sells its products through a direct sales force, distributors, and third-party sales representatives. It has collaboration agreements with PLX Technology Inc.; Neonode, Inc.; and Ubiquisys Ltd. The company was founded in 1938 and is headquartered in Dallas, Texas.
Advisors' Opinion:- [By Dan Caplinger]
Next Monday, Texas Instruments (NASDAQ: TXN ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise.
- [By Paul Ausick]
Texas Instruments Inc. (NASDAQ: TXN) saw short interest fall by 2.1% to 22.85 million shares, or 2.1% of the float. TI reported earnings last week, pulling the shares back from a 52-week high and cooling, for the moment at least, any added interest from short sellers.
- [By Chuck Saletta]
Texas Instruments (NASDAQ: TXN ) is a selection for the real-money Inflation-Protected Income Growth portfolio. In this brief video, portfolio manager Chuck Saletta offers two-and-a-half reasons he's holding on to Texas Instruments' stock despite its substantial rise since he bought those shares a little more than a year ago.
No comments:
Post a Comment